ARIAD Pharma (ARIA) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.11 --0%
Financial Fact:
Research and development: 43.63M
Today's EPS Names:
ANAB, ANIX, MNY, More
Financial Fact:
Research and development: 43.63M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
ARIAD Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $23.9 million versus the consensus estimate of $27.26 million.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group
- GE Vernova (GEV) PT Raised to $1,185 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
